SCHEMBL149354

SCHEMBL149354

[Na+].[Se-]c1ccccc1

nearest known ligand 0.00

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Silver SCHEMBL19899711 0.92 TDP1 (0.41) —
Potassium Ion SCHEMBL9089761 0.92 — —
Lithium Ion SCHEMBL9090012 0.92 — —
Silver SCHEMBL19899724 0.92 — —
Benzenethiol SCHEMBL11013381 0.75 TSHR (0.32) —
SCHEMBL2962836 0.70 — —
SCHEMBL28069 0.70 — —
SCHEMBL3808897 0.67 — —
SCHEMBL9161603 0.67 — —
SCHEMBL1820268 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-60209562-A — — None — — JP disclosed
US-10828371-B2 Multifunctionalized bioactive polycaprolactone INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2020-11-10 — — US disclosed
US-20190134209-A1 MULTIFUNCTIONALIZED BIOACTIVE POLYCAPROLACTONE INTERNATIONAL BUSINESS MACHINES CORPORATION 2019-05-09 — — US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 — — US disclosed
EP-2440542-B1 Substituted benzimidazoles, benzonthiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2013-12-18 — — EP disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 — — US disclosed
EP-2611810-A1 SUBSTITUTED TETRAHYDROPYRROLOPYRAZINE DERIVATIVES Grünenthal GmbH (DE) 2013-07-10 — — EP disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 — — US disclosed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 — — US disclosed
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 — — US disclosed
WO-2002032856-A2 INSECTICIDAL 1,8-NAPHTHALENEDICARBOXAMIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2002-04-25 — — WO disclosed
WO-2001085709-A2 NEW COMPOUNDS HAVING ANTICANCER ACTIVITY: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S RESEARCH FOUNDATION (IN) 2001-11-15 — — WO disclosed
US-5489613-A TREATING THROMBOSIS SANKYO COMPANY, LIMITED (JP) 1996-02-06 — — US disclosed
US-5405870-A Platelet-aggregation inhibitors; useful in treatment of thrombosis SANKYO COMPANY, LIMITED (JP) 1995-04-11 — — US disclosed
US-5075327-A Antipsoriatic agents HOFFMANN-LA ROCHE INC. (US) 1991-12-24 — — US disclosed
EP-0211954-B1 USE OF (+/-)-CIS-GAMMA-IRONE IN PERFUMERY AND NOVEL PROCESS FOR PREPARING SAME T. HASEGAWA COMPANY, LTD. (JP) 1991-07-17 — — EP disclosed
EP-0136779-B1 NEW CARBACYCLIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM SANKYO COMPANY LIMITED (JP) 1988-09-14 — — EP disclosed
JP-S60209562-A PRODUCTION OF (+-)-CIS-GAMMA-TRONE AND ITS UTILIZATION T HASEGAWA CO LTD 1985-10-22 — — JP disclosed
EP-0136779-A1 New carbacyclin derivatives, processes for their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1985-04-10 — — EP disclosed
US-3970676-A Novel process and intermediate compounds used is preparation of -Δ5,7- steroid dienes THE UPJOHN COMPANY (US) 1976-07-20 — — US disclosed
Send feedback